Files
Download Full Text (8.0 MB)
Contents
- Outwitting unknown primary tumors
- Synthetic peptide effectively controls the spread of HIV in human cell cultures
- Biological response modifiers promising adjuvants to cancer therapy
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Publication Date
1994
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Raber, Martin N.; Abbruzzese, James L.; Bar-Eli, Menashe; Vadhan-Raj, Saroj; Murray, James Lee; Sastry, K. Jagannadha; Arlinghaus, Ralph B.; Nehete, Pramod; Lenzi, Renata; Neoplasms, Unknown Primary; Neoplasm Metastasis; Unknown Primary Tumor Clinic; Antineoplastic Agents; Neoplasms -- diagnosis; Surgical Procedures, Operative; Radiotherapy; Fluorouracil; Leucovorin; Cisplatin; Paclitaxel; Cell Line; Genes, Tumor Suppressor; Oncogenes; Genes, p53; Chemotherapy, Adjuvant; Immunologic Factors; DNA, Recombinant; Molecular Biology; Biological Therapy; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Interleukin-3; Interleukins; Sarcoma; Hematopoietic Stem Cells; S Phase; Antibodies, Monoclonal; Immunoconjugates; Acquired Immunodeficiency Syndrome; Chemistry Techniques, Synthetic; Zidovudine; T-Lymphocytes; Immunity, Cellular; AIDS Vaccines; Clinical Trials as Topic; Lymphoma, B-Cell; Sarcoma, Kaposi; BR96-doxorubicin immunoconjugate; Doxorubicin; BR96 monoclonal antibody.
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Williams, Vickie J. and Hale, Kathryn L., "OncoLog, Volume 39, Number 02 April-June 1994" (1994). OncoLog MD Anderson's Report to Physicians (All issues). 44.
https://openworks.mdanderson.org/oncolog/44
Conditions Governing Access
Open
